George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
"I have colleagues in the healthworkers arm of the vaccine trial who need regular NP swabs and blood test for antibodies to monitor response."
My other half is in the trial as well (he's a consultant at major teaching hospital and often in contact with Covid patients). He gets weekly tests.
Agree @maxdba.
I have colleagues in the healthworkers arm of the vaccine trial who need regular NP swabs and blood test for antibodies to monitor response.
If the vaccine is shown to work, routine testing won’t be needed. If it’s only partial response then maybe it will.
doctorv - I suspect that the other vaccine programmes that you mention are mature well developed solutions
The market for this test is huge, but I don’t see it necessarily being used routinely in the vaccine program.
You’re correct that antibody testing is used for HepB. As a healthcare worker I was tested 10 years after my first injection and given a booster. However there was no testing after the initial two jabs.
Looking at the other mass testing programs - Flu, MMR, HPV, meningitis - none have antibody testing.
doctor,
You cant vaccinate someone who already has antibodies. They already tried that in India and realised there is no immune response detected.... because there already was one.
Doctorv,
Sorry you are wrong , antibody testing will be needed with every vaccine , like hep b . Because they don’t know how long you get immunity as a vaccine is being rushed out . So they have to test to see how long it lasts and also after each vaccine to know whether it worked in an individual . No vaccine is 100%
“ antibody test will be needed before administering vaccine and after as well to check if it has worked”
Antibody testing will certainly be required in the Phase 3 trials and possibly in the early part of the roll out. But in the routine vaccination program? Unlikely. Antibodies are not checked for any other vaccine.
"antibody test will be needed before administering vaccine and after as well to check if it has worked."
There will be around 200m test needed in the UK each year.
We now know the RTC test is the de-facto gold standard and will be used nationally.
This is not a one off contract, this will be happening regularly from now on.
That means ODX can sell everything they can produce.
It follows on from that, that ODX revenue next year should be in excess of £500m
Aberdeenman
not that i am greedy or anything, but i would be happy with a £410 million order :-)
I think we are locked for the rise now. Faarting about could be done with*. Maybe. An RNS associated with this order should help. *Then again, this is ODX and this is AIM, so there will be loads of pants-pulling to go yet, I am sure.
The only covid stock that will be needed for next 20 years.
antigens will not last after vaccine.
antibody test will be needed before administering vaccine and after as well to check if it has worked.
LOAD UP and lock it in.
it seems trader getting out just now but MMs will add 10 - 15 % on this still before close.